Dulaglutide
INTERCEPT
Company n/r · Phase n/r · Completed · Enrollment 60000
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Initiation of dulaglutide, semaglutide or tirzepatide | n/r | n/r | n/r | n/r | n/r |
| Initiation of sitagliptin | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.